Cite
HARVARD Citation
Salvatore, D. et al. (2020). Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. Respiratory medicine. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Salvatore, D. et al. (2020). Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. Respiratory medicine. p. . [Online].